FOXD2 and acute myeloid leukemia: Based on the GSE68172 dataset, FOXD2-AS1 exhibited significant overexpression in primary AML samples compared to healthy control (as depicted in Supplementary Fig. 1A), with a logFC of 1.65190288 and a p-value of 2.52E-03.